Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies directed against nerve growth factor (NGF)

Antibodies directed against nerve growth factor (NGF)

US Patent 9951126 · Granted Apr 24, 2018

Estimated economic value: $60,115,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

TNF-alpha variant fusion molecules2025
Compositions comprising anti-NRP2 antibodies2025
Antibodies directed against interleukin 36 receptor (IL-36R)2025
Antibodies directed against interleukin 36 receptor (IL-36R)2025
Anti-IL-18BP antibodies2025
Anti-IL-18BP antibodies2025
Method of treating an interleukin-11-associated or -mediated fibrotic disease or2025
Method of treating an interleukin-11-associated or -mediated fibrotic disease or2025
Anti-interleukin-11 receptor subunit α (IL-11Rα) antibodies2024
Anti-interleukin-11 receptor subunit α (IL-11Rα) antibodies2024
Claudin-6 antibodies and drug conjugates2024
Compositions and methods comprising anti-NRP2 antibodies2024